Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 13/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | BACE2 | Q9Y5Z0 | 4/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7917963 | 0.96 | BACE1 (0.43) | BACE1TAAR1ADRA2AMEN1KMT2A | |
| SCHEMBL7921968 | 0.91 | MEN1 (0.42) | BACE1MEN1KMT2AKCNH2BACE2 | |
| SCHEMBL7920108 | 0.84 | BACE1 (0.45) | BACE1TAAR1ADRA2AKCNH2BACE2 | |
| SCHEMBL7924845 | 0.79 | CYP1A2 (0.42) | BACE1ADRA2ABACE2 | |
| SCHEMBL7918363 | 0.78 | TAAR1 (0.51) | BACE1TAAR1ADRA2AMEN1KMT2A | |
| SCHEMBL7918614 | 0.78 | TAAR1 (0.51) | BACE1TAAR1ADRA2AMEN1KMT2A | |
| SCHEMBL7919840 | 0.78 | TAAR1 (0.51) | BACE1TAAR1ADRA2AMEN1KMT2A | |
| SCHEMBL7918622 | 0.78 | ADRA2A (0.60) | BACE1TAAR1ADRA2AMEN1KMT2A | |
| SCHEMBL7913188 | 0.77 | BACE1 (0.39) | BACE1KMT2AKCNH2BACE2 | |
| SCHEMBL7913281 | 0.76 | TAAR1 (0.40) | BACE1TAAR1ADRA2AKCNH2BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010042475-A1 | SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS | SCHERING CORPORATION (US) | 2010-04-15 | — | — | WO | disclosed |